A Step Forward in the Fight Against Dementia

This Viewpoint reports on the results of the Clarity AD trial, a phase 3 randomized clinical trial of lecanemab for patients with early Alzheimer disease, in which lecanemab ’s clinical efficacy was demonstrated using well-established outcome measures.
Source: JAMA Neurology - Category: Neurology Source Type: research